Novel therapeutic choices in immune aplastic anemia [version 1; peer review: 2 approved]

Aplastic anemia (AA) in its severe form has historically been associated with high mortality. With limited supportive care and no effective strategy to reverse marrow failure, most patients diagnosed with severe AA (SAA) died of pancytopenia complications. Since the 1970s, hematopoietic stem cell tr...

Full description

Bibliographic Details
Main Author: Phillip Scheinberg
Format: Article
Language:English
Published: F1000 Research Ltd 2020-09-01
Series:F1000Research
Online Access:https://f1000research.com/articles/9-1118/v1